Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
Details for Australian Patent Application No. 2005237360 (hide)
International Classifications
Event Publications
26 April 2007 Section 223 Application Allowed
Astellas Pharma Inc. The time in which to enter the National Phase has been extended to 28 Feb 2007. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000
10 May 2007 PCT application entered the National Phase
PCT publication WO2005/105045 Priority application(s): WO2005/105045
21 October 2010 Application Accepted
Published as AU-B-2005237360
17 February 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005237364-Method for reducing gastrointestinal toxicity due to the administration of tegafur
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser